Your shopping cart is currently empty

IAB15 is a highly selective GSK-3beta inhibitor with dual potential in neuroregeneration and cell cycle regulation. It activates Wnt/beta-catenin signaling by blocking GSK-3beta, protecting dopaminergic neurons from apoptosis and exerting anti-proliferative effects on cancer cells.

| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 10-14 weeks | 10-14 weeks | |
| 50 mg | $1,980 | 10-14 weeks | 10-14 weeks | |
| 100 mg | $2,500 | 10-14 weeks | 10-14 weeks |
| Description | IAB15 is a highly selective GSK-3beta inhibitor with dual potential in neuroregeneration and cell cycle regulation. It activates Wnt/beta-catenin signaling by blocking GSK-3beta, protecting dopaminergic neurons from apoptosis and exerting anti-proliferative effects on cancer cells. |
| In vitro | IAB15 (50 uM) significantly reduces current density from T-type Ca2+ channels in ND7/23 cells, showing selective inhibition [1]. |
| In vivo | In epilepsy models, IAB15 shows anticonvulsant activity by modulating T-type Ca2+ channel kinetics to suppress abnormal firing [1]. |
| Molecular Weight | 297.27 |
| Formula | C15H14F3NO2 |
| Cas No. | 2987139-91-1 |
| Smiles | O=C1C=C(NC(=O)C2=CC=CC(=C2)C(F)(F)F)CC(C)C1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.